Researcher spotlights new biomarker for gliomas

An investigator at the Oklahoma Medical Research Foundation says he used data mining and bioinformatics tech to identify a new biomarker for gliomas, the most common kind of brain cancer. The biomarker ELTD1 "may serve as an additional biomarker for gliomas in preclinical and clinical diagnosis of gliomas," according to the study by Rheal A. Towner. Towner's work suggests that high levels of ELTD1 expression are linked to a "higher grade of glioma, and with lower survival." Report

 

 

Suggested Articles

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.

Cybernet Manufacturing, maker of medical-grade computer monitors, has unveiled a new, large touchscreen designed to protect against infections.

A startup has raised $12 million to fund its real-time system for monitoring patients undergoing dialysis at home and calling in complications.